arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Bioventus Inc.

BVS

$10.67 ▼ -0.74 (-6.53%) at close

7 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bearish

auto_awesome

Analytical Summary

Bioventus Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $710.9M

Dividend Yield —

Revenue Growth -0.9% ↘

Op. Margin 9.5% ↗

ROIC 12.4% ↗

FCF / Share $1.08 ↗

Trailing P/E 31.4x

Price / Book 3.9x

FCF Yield 10.1%

Debt / Equity 1.52

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$568.09M

↓ -0.9% —

Net Income Profit after all expenses

$22.73M

↑ +162.9% —

Operating Margin Operating profit as % of sales

9.5%

↑ +458.5% 55th

FCF / Share Free cash flow per share

$1.08

↑ +84.9% —

Long-Term Debt Long-term obligations

$278.95M

↓ -9.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-0.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-111%)	11.9% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+49%)	0.0% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-99%)	18.8% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+136%)	34.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+327%)	-5.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-170%)	—
EPS Growth YoY (%)	N/M	77.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	3.9% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	-1626.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	N/M	76.9% Excellent ↑ Excellent Improving Year-over-year change in net income	1.6% Caution ↓ Caution Declining Year-over-year change in net income	N/M	18.1% Good Good Year-over-year change in net income	139.5% Excellent Excellent Year-over-year change in net income	—
FCF Growth YoY (%)	84.9% Excellent Excellent Year-over-year change in free cash flow	359.5% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	—	—	—
Revenue CAGR 3Y (%)	3.5% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	10.0% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	16.8% Excellent Excellent Compound annual revenue growth over 3 years	14.6% Good Good Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	12.1% Excellent Excellent Compound annual revenue growth over 5 years	11.0% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	9.5% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-37%)	-2.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-118%)	-16.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-206%)	-49.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-427%)	2.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-81%)	6.6% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-56%)	9.2% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-39%)
Effective Tax Rate (%) (%)	-6.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.1% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-25.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	16.3% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	4.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-67%)	-6.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-153%)	-30.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-354%)	-31.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-358%)	4.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-63%)	5.1% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-57%)	2.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-83%)
FCF Margin (%) (%)	12.7% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	1.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-4.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	3.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	21.1% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	11.3% Fair Fair Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	3.17x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	4.13x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	5.60x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	12.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	11.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	7.9% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	-2.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	4.3% Caution Caution Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	12.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	-24.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-90.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-700%)	-50.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-434%)	4.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-72%)	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	1.52x Weak ↓ Weak Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+153%)	2.08x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+247%)	2.11x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+252%)	1.22x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+103%)	0.74x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+23%)	—	—
Net Debt (USD)	$227.71M	$266.71M	$330.03M	$353.20M	$295.71M	$86.54M	—
Debt / EBITDA (x)	2.76x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	8.97x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-15.07x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.09x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	7.24x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	3.48x Caution Caution Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$8.53	$8.88	$8.18	$8.34	$9.48	—	—
Basic EPS, GAAP (USD)	$0.34	$-0.56	$-2.49	$-2.59	$-0.15	—	—
Free Cash Flow per Share (USD)	$1.08	$0.59	$0.13	$-0.38	$0.34	—	—
Book Value per Share (USD)	$2.76	$2.29	$2.77	$5.16	$10.09	—	—
Tangible Book Value per Share (USD)	$-2.88	$-4.09	$-5.05	$-11.99	$-8.44	—	—
Basic Weighted Avg Shares (shares)	66.62M	64.55M	62.65M	61.39M	45.47M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$112.46M	$65.21M	$92.50M	$-31.44M	$82.24M	$89.20M	—
LT Debt (USD)	$278.95M	$308.29M	$367.00M	$385.01M	$339.64M	$173.38M	—
Total Equity (USD)	$184.10M	$147.94M	$173.59M	$316.58M	$458.92M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$568.09M	$573.28M	$512.35M	$512.12M	$430.90M	$321.16M	$340.14M
Depreciation Expense (USD)	$47.01M	$49.55M	$57.37M	$66.80M	$34.88M	$28.64M	$30.32M
Net Income, GAAP (USD)	$22.73M	$-36.12M	$-156.23M	$-158.70M	$19.38M	$16.41M	$6.85M
Operating Cash Flow (USD)	$74.67M	$38.80M	$15.34M	$-13.54M	$22.99M	$71.80M	$40.71M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 27 quarters

Bioventus Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BVS with peers